| 21267/34348 | US=28 / Biol/Mol Nagy JA, Fu Y, Dvorak AM, Dvorak HF. Tumor blood vessels. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 205-24. ISBN 978-1-58829-870-6. VEGF-A; VASOS SANGUINEOS TUMORAIS; ANGIOGENESE; ARTERIOGENESE; VENOGENESIS |
| 21268/34348 | US=28 / Urologia Orris BG, Flanigan RC. Nephrectomy in patients with metastatic renal cell carcinoma: clinical and biologic effects. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 335-53. ISBN 978-1-58829-251-3. NEFRECTOMIA; CARCINOMA DE CELULAS RENAIS METASTATICO. PACIENTES COM NEFRECTOMIA |
| 21269/34348 | US=28 / Urologia Oliver T, Powles T, Narrgund V, Berney D. Spontaneous regression of renal cell carcinoma and the role of prognostic factors. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 355-66. ISBN 978-1-58829-251-3. REGRESSAO ESPONTANEA DE CARCINOMA; CARCINOMA DE CELULAS RENAIS; PROGNOSTICOS; PARAMETROS SANGUINEOS PERIFERICOS |
| 21270/34348 | US=28 / Urologia Jin JO, Stadler WM. Chemotherapy for metastatic clear-cell renal cell carcinoma. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 385-97. ISBN 978-1-58829-251-3. QUIMIOTERAPIA PARA CARCINOMA DE CELULAS RENAIS DE CELULAS CLARAS; AGENTE UNICO DE QUIMIOTERAPIA; TERAPIA HORMONAL; TERAPIA COMBINADA CHEMOHORMONAL |
| 21271/34348 | US=28 / Urologia Ronnem EA, George S, Bukowski RM, Motzer RJ. Signal transduction inhibitors in renal cell carcinoma. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 399-413. ISBN 978-1-58829-251-3. INIBIDORES DE TRANSDUCAO DE SINAL EM CARCINOMA DE CELULAS RENAIS; CARCINOMA DE CELULAS RENAIS METASTATICO; PAPILAR CARCINOMA DE CELULAS RENAIS |
| 21272/34348 | US=28 / Biol/Mol Pytowshi B. Lymphatic system in the pathology of cancer. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 225-41. ISBN 978-1-58829-870-6. SISTEMA LINFATICO NA PATOLOGIA DO CANCRO; CELULAS ENDOTELIAIS; LINFA; LINFONODOS; VASOS LINFATICOS; CANCER; DESENVOLVIMENTO; METASTASE |
| 21273/34348 | US=28 / Biol/Mol Maharaj ASR, D'Amore PA. VEGF in the adult. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 245-59. ISBN 978-1-58829-870-6. VEGF; ANGIOGENESE; PRE-ECLAMPSIA; TERAPIA ANTI-ANGIOGENICA; BEVACIZUMAB; CELULAS ENDOTELIAIS |
| 21274/34348 | US=28 / Biol/Mol Jain RK, Batchelor TT, Duda DG, Willett CG. Normalization of tumor vasculature and microenvironment. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 261-76. ISBN 978-1-58829-870-6. |
| 21275/34348 | US=23 / Câncer Hayat MA. Breast cancer: an introduction. In: ___. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 1-3. ISBN 978-1-4020-8368-6. |
| 21276/34348 | US=23 / Câncer Zheng B. Breast cancer: computer-aided detection. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 5-27. ISBN 978-1-4020-8368-6. CANCER DE MAMA. DETECCAO; COMPUTADOR; CAD; DIAGNOSTICO AUXILIADO POR COMPUTADOR |
| 21277/34348 | US=23 / Câncer Hisaoka M, Hamada T. Sebaceous carcinoma of the breast: clinicopathologic features. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 29-32. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CARCINOMA SEBACEO DA MAMA; CARACTERISTICAS CLINICO-PATOLOGICAS |
| 21278/34348 | US=28 / Biol/Mol Kerbel RS, Emmenegger U, Folkins C, Munoz R, Shaked Y. Metronomic low-dose antiangiogenic chemotherapy in mice and man. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 277-96. ISBN 978-1-58829-870-6. BAIXA DOSE DE QUIMIOTERAPIA; ANGIOGENESE TUMORAL; TERAPIA ANTIANGIOGENICA; ENSAIOS CLINICOS; CELULAS PROGENITORAS ENDOTELIAIS; VEGF; METASTASE; CANCER DE MAMA; CANCRO DO OVARIO; CICLOFOSFAMIDA |
| 21279/34348 | US=28 / Biol/Mol Siemann DW, Horsman MR. Small-molecule vascular disrupting agents in cancer therapy. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 297-310. ISBN 978-1-58829-870-6. |
| 21280/34348 | US=23 / Câncer Bach-Gansmo T, Tobin D. Breast cancer: detection by in-vivo imaging of angiogenesis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 33-42. ISBN 978-1-4020-8368-6. CANCER DE MAMA; ANGIOGENESE IN VIVO; INTEGRINAS; CINTILOGRAFIA; TC-NC100692; EXPERIENCIA CLINICA INICIAL; RAIOS GAMA; CAMARA GAMA |
| 21281/34348 | US=28 / Biol/Mol Mendoza E, Burd R, Wachsberger P, Dicker AP. Normalization of tumor vasculature and improvement of radiation response by antiangiogenic agents. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 311-21. ISBN 978-1-58829-870-6. ANGIOGENESE; AGENTES ANTI-ANGIOGENICOS; CANCER; CLINICO; PRE-CLINICO; NORMALIZACAO; TUMOR; RESPOSTA RADIACAO; TERAPIA DE RADIACAO; OXIGENACAO DO TUMOR; VASCULATURA |
| 21282/34348 | US=28 / Biol/Mol Ellis LM, Dallas NA, Buren II GV, Lim S, Xia L, Fan F, Gray MJ. Challenges in translating antiangiogenic therapy from the bench to bedside. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 323-30. ISBN 978-1-58829-870-6. ANGIOGENESE; FARMACOCINETICA; DOSE MAXIMA TOLERADA; INTEGRIDADE; INVESTIGACAO TRANSLACIONAL |
| 21283/34348 | US=28 / Biol/Mol Han L, Lorincz AM, Sukumar S. Regulation of angiogenesis in cancer and its therapeutic implications. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 331-49. ISBN 978-1-58829-870-6. |
| 21284/34348 | US=23 / Câncer Mattie MD, Getts RC. Breast and prostate biopsies: use of optimized high-throughput microRNA expression for diagnosis (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 43-59. ISBN 978-1-4020-8368-6. CANCER DE MAMA. DIAGNOSTICO; BIOPSIAS; USO DE EXPRESSAO DE MICRORNA; METODOLOGIA |
| 21285/34348 | US=28 / Biol/Mol DuBois S, Demetri G. Angiogenesis and angiogenesis inhibition in sarcomas. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 353-69. ISBN 978-1-58829-870-6. |
| 21286/34348 | US=28 / Biol/Mol Grothey A. Antiangiogenesis agents in colorectal cancer. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 371-84. ISBN 978-1-58829-870-6. |